Sfoglia per AUTORE
LIBERATO NL
Collezione ASL Asti

  

Items : 5

2021
ASL Torino 4
ASL Asti

D'Avanzo B; Nobili A; Tettamanti M; Pasina L; Mannucci PM; Pietrangelo A; Perticone F; Violi F; Corazza GR; Corrao S; Marengoni A; Salerno F; Cesari M; Franchi C; Cortesi L; Miglio G; Ardoino I; Novella A; Prisco D; Silvestri E; Emmi G; Bettiol A; Mattioli I; Biolo G; Zanetti M; Bartelloni G; Vanoli M; Grignani G; Pulixi EA; et alii...

2021
ASL Torino 4
ASL Asti

Pepe J; Agosti P; Cipriani C; Tettamanti M; Nobili A; Colangelo L; Santori R; Cilli M; Minisola S; Mannucci PM; Pietrangelo A; Perticone F; Violi F; Corazza GR; Corrao S; Marengoni A; Salerno F; Cesari M; Pasina L; Cortesi CFL; Miglio G; Ardoino I; Novella A; Prisco D; Silvestri E; Emmi G; Bettiol A; Mattioli I; Biolo G; et alii...

Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):221-35. doi: 10.1586/14737167.2016.1147351. Epub 20
2016
ASL Asti

Liberato NL; Marchetti M;

Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analyses. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):815-24. doi: 10.1586/14737167.2014.957682. Epub
2014
ASL Asti

Marchetti M; Liberato NL;

Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease. in The European journal of health economics : HEPAC : health economics in prevention and care / Eur J Health Econ. 2013 Dec;14(6):853-61. doi: 10.1007/s10198-012-0430-7. Epub 2012 Sep 14.
2013
ASL Asti

Marchetti M; Liberato NL; Di Sabatino A; Corazza GR;